Preparing for the Future - Nanobodies for Covid-19?

N Engl J Med. 2021 Apr 22;384(16):1568-1571. doi: 10.1056/NEJMcibr2101205. Epub 2021 Apr 7.

Author

Ram Sasisekharan¹

Affiliation

¹ From the Koch Institute for Integrative Cancer Research, Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge.

PMID: 33826817
DOI: 10.1056/NEJMcibr2101205

No abstract available

MeSH terms

Animals
Antibodies, Bispecific / chemistry
Antibodies, Neutralizing / immunology
Antibodies, Neutralizing / metabolism
Antibodies, Viral / immunology*
Antibodies, Viral / metabolism
Antibody Affinity
Binding Sites, Antibody
COVID-19 / immunology*
Humans
SARS-CoV-2 / immunology*
SARS-CoV-2 / metabolism
Single-Domain Antibodies / chemistry
Single-Domain Antibodies / immunology*
Single-Domain Antibodies / metabolism
Single-Domain Antibodies / therapeutic use
Spike Glycoprotein, Coronavirus / metabolism*

Substances

Antibodies, Bispecific
Antibodies, Neutralizing
Antibodies, Viral
Single-Domain Antibodies
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2
blinatumomab